Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

440 public trials 66 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT05564390

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 350 locations
View Trial Details
Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

NCT06577441

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Mills Health Center San Mateo, California, United States
View all 144 locations
View Trial Details
Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT07422480

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope - Comprehensive Cancer Center (CCC) Duarte, California, United States
  • Providence Medical Group Santa Rosa, California, United States
  • University of Miami Miami, Florida, United States
View all 162 locations
View Trial Details
Recruiting

Collection of Tissue Samples for Cancer Research

NCT00900198

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Colorado, Denver Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University - Purdue Indianapolis, Indiana, United States
View all 17 locations
View Trial Details
Recruiting

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

NCT03471260

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +13 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions